iHuman EBIT

iHuman (IH) currently reports a EBIT of $21M as of March 2026. That compares with $76M in the prior-year period — down 71.8% year over year. That is above the sector sector average of $-6.4M. Use the charts on this page to explore iHuman's EBIT history and peer comparisons.

iHuman's EBIT decreased from $76M to $21M — a 71.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

iHuman's EBIT of $21M is higher than the its sector sector average of $-6.4M. That is roughly 434.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

iHuman reported $21M in EBIT as of March 2026. That compares with $76M in the prior-year period — down 71.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for iHuman, and consider following IH for alerts when major investors trade the stock.